20240036060. OPTIMAL COMBINATION OF EARLY BIOMARKERS FOR INFECTION AND SEPSIS DIAGNOSIS IN EMERGENCY DEPARTMENT simplified abstract (INSTITUT PASTEUR)
Contents
OPTIMAL COMBINATION OF EARLY BIOMARKERS FOR INFECTION AND SEPSIS DIAGNOSIS IN EMERGENCY DEPARTMENT
Organization Name
Inventor(s)
Jean-Marc Cavaillon of CHAVILLE (FR)
Pierre Hausfater of PARIS (FR)
Catherine Fitting of CHAVILLE (FR)
Stevenn Volant of CLAMART (FR)
Florian Salipante of NIMES (FR)
Jeannette Fareh of SAUSSINES (FR)
OPTIMAL COMBINATION OF EARLY BIOMARKERS FOR INFECTION AND SEPSIS DIAGNOSIS IN EMERGENCY DEPARTMENT - A simplified explanation of the abstract
This abstract first appeared for US patent application 20240036060 titled 'OPTIMAL COMBINATION OF EARLY BIOMARKERS FOR INFECTION AND SEPSIS DIAGNOSIS IN EMERGENCY DEPARTMENT
Simplified Explanation
The present invention aims to provide a rapid and early diagnosis of bacterial or viral infection, which is highly desired in emergency departments to initiate appropriate treatment. The invention recognizes that no single biomarker can offer a diagnosis with sufficient sensitivity and specificity, so it defines optimal combinations of biomarkers for accurate infection diagnosis.
- The invention allows for a quick and early diagnosis of bacterial or viral infection.
- It is particularly useful in emergency departments to initiate appropriate treatment promptly.
- The invention identifies optimal combinations of biomarkers for accurate infection diagnosis.
- No single biomarker alone can provide a diagnosis with sufficient sensitivity and specificity.
- The invention helps in defining the appropriate treatment for patients admitted with infections.
Potential Applications:
- Emergency departments and hospitals can utilize this invention for rapid infection diagnosis.
- Medical professionals can use the defined biomarker combinations to initiate appropriate treatment promptly.
Problems Solved:
- The invention addresses the challenge of accurately diagnosing bacterial or viral infection.
- It overcomes the limitation of relying on a single biomarker for infection diagnosis.
- The invention helps in avoiding delays in initiating the appropriate treatment.
Benefits:
- Early and accurate diagnosis of infection allows for timely treatment initiation.
- The invention improves patient outcomes by ensuring appropriate treatment is provided promptly.
- It helps in reducing the risk of complications associated with delayed or incorrect treatment.
Original Abstract Submitted
the present invention allows a rapid and early diagnosis of bacterial or viral infection. such a diagnosis is highly desired among patients admitted in emergency department to allow the initiation of the appropriate treatment. although no biomarker alone can offer an appropriate diagnosis with sufficient sensitivity and specificity, the present invention defines optimal combinations of biomarkers allowing the diagnosis of infection.